During the past decade, Centre Hospitalier Hutois conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 7 clinical trials were completed, i.e. on average, 350% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier Hutois" #1 sponsor was "ETOP IBCSG Partners Foundation" with 3 trials, followed by "The Lymphoma Academic Research Organisation" with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Groupe Regional d'Etudes du Cancer Colorectal" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Hutois" #1 collaborator was "Breast International Group" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Hutois" are "Breast Cancer" (5 trials), "Cardiovascular Disease" (2 trials), "Brady Tachy Syndrome" (1 trials), "Colorectal Cancer" (1 trials) and "Diffuse Large B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Centre Hospitalier Hutois" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Hutois" are "Drug" (11 trials), "Procedure" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "cyclophosphamide" (2 trials), "fluorouracil" (2 trials) and "2LHERP®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Hutois" are 9 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier Hutois". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Centre Hospitalier Hutois, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Hutois, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".